专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20050060175A1 System and method for comparing candidate responses to interview questions 审中-公开
标题翻译：用于将候选人答复与面试问题进行比较的系统和方法
公开(公告)号：US20050060175A1
公开(公告)日：2005-03-17
申请号：US10896525
申请日：2004-07-22
申请人： Michael Farber , Hal Cohen
发明人： Michael Farber , Hal Cohen
IPC分类号： G09B7/02 , G06F17/60 , A61B5/04 , G09B3/00 , G09B7/00 , G09B19/18
CPC分类号： G09B7/02 , G06Q10/1053
摘要： A system and method for interviewing candidates and comparing candidate responses to interview questions includes an interactive voice response unit that automatically interviews the first and second candidates by sequentially prompting each candidate with the stored interview questions; and stores verbal responses of the candidates in a database.
摘要翻译：用于面试候选人并将候选答复与面试问题进行比较的系统和方法包括：交互式语音应答单元，通过依次提示每个候选人存储的面试问题来自动访问第一和第二候选人; 并将候选人的口头答复存储在数据库中。

2. 发明授权

US11903962B1 Isoxazoline complexes and compositions thereof 有权
公开(公告)号：US11903962B1
公开(公告)日：2024-02-20
申请号：US18212233
申请日：2023-06-21
申请人： Michael Farber
发明人： Michael Farber
IPC分类号： A61K31/724 , A61K9/00 , A61P33/14 , A61K31/42
CPC分类号： A61K31/724 , A61K9/0056 , A61K31/42 , A61P33/14
摘要： A pharmaceutical composition comprising an isoxazoline compound complexed with a cyclodextrin such as hydroxy-propyl-cyclodextrin and combined in a dry (anhydrous) composition with polypowder. The composition can be a mixture of isomers, an enriched mixture of a specific enantiomer or a single enantiomer.

3. 发明授权

US08946160B2 Nitric oxide amino acid esters for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation 有权
标题翻译：用于改善血管循环的一氧化氮氨基酸酯，以及预防或治疗与血液循环受损有关的病症
公开(公告)号：US08946160B2
公开(公告)日：2015-02-03
申请号：US13881867
申请日：2011-10-26
申请人： Michael Farber
发明人： Michael Farber
IPC分类号： A61K38/00 , A61P9/00 , C07C229/12 , C07C229/22 , A61K45/06 , A61K31/223
CPC分类号： A61K31/223 , A61K31/216 , A61K31/401 , A61K31/405 , A61K31/4172 , A61K45/06 , C07C229/12 , C07C229/22
摘要： Use of nitric oxide amino acid esters for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation, such as peripheral vascular disease. The nitric oxide amino acid esters may be co-administered with an antimicrobial in topical or transdermal compositions for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation.
摘要翻译：使用一氧化氮氨基酸酯来改善血管循环，并预防或治疗与血液循环受损有关的疾病，如外周血管疾病。一氧化氮氨基酸酯可与用于改善血管循环的局部或透皮组合物中的抗微生物剂共同施用，以及预防或治疗与血液循环受损有关的病症。

4. 发明申请

US20160361257A1 COMPOSITION FOR INCREASING TESTOSTERONE LEVELS AND ENHANCING LIBIDO 审中-公开
标题翻译：用于增加TESTOSTERONE水平和增强LIBIDO的组合物
公开(公告)号：US20160361257A1
公开(公告)日：2016-12-15
申请号：US14735200
申请日：2015-06-10
申请人： Michael Farber
发明人： Michael Farber
IPC分类号： A61K9/127 , A23L1/236 , A61K9/00 , A23L1/22 , A61K31/341 , A61K31/352
CPC分类号： A61K9/127 , A23L27/00 , A23L27/30 , A23V2002/00 , A61K9/006 , A61K9/145 , A61K31/341 , A61K31/352 , A61K2300/00
摘要： The present invention features a compressible delivery formulation for buccal delivery, dosage forms and methods of using the same for increasing testosterone levels in a subject. The formulation, dosage forms and methods comprise effective amounts of 3,4-divanillyltetrahydrofuran, 7-methoxyflavone, 7,8-benzoflavone.
摘要翻译：本发明的特征在于用于口腔递送的可压缩递送制剂，剂型以及使用其可用于增加受试者中睾丸激素水平的方法。制剂，剂型和方法包括有效量的3,4-二苯基四氢呋喃，7-甲氧基黄酮，7,8-苯并异黄酮。

5. 发明授权

US09085508B2 Nitric oxide releasing amino acid ester compound, composition and method of use 有权
标题翻译：一氧化氮释放氨基酸酯化合物，组成及使用方法
公开(公告)号：US09085508B2
公开(公告)日：2015-07-21
申请号：US14069630
申请日：2013-11-01
申请人： Michael Farber
发明人： Michael Farber
IPC分类号： A61K31/22 , C07C205/02 , C07C229/20 , A61K31/215 , A61K45/06 , C07C323/58 , C07C229/12 , C07C229/22 , C07C229/24 , C07C229/36 , C07C391/00
CPC分类号： C07C229/20 , A61K31/215 , A61K45/06 , C07C229/12 , C07C229/22 , C07C229/24 , C07C229/36 , C07C323/58 , C07C391/00
摘要： There is provided amino acid ester compounds comprising at least one nitric oxide releasing group, pharmaceutically acceptable salts thereof and compositions thereof. These compounds involve an amino acid side-chain or an amino acid derivative thereof and a nitric oxide releasing group as depicted in the following structures: wherein R1 is either an ethyl or an amino acid side-chain group or an amino acid derivative thereof and R2 is an amino acid side-chain group or an amino acid derivative thereof and n is an integer from 1 to 10.
摘要翻译：提供了包含至少一种一氧化氮释放基团的氨基酸酯化合物，其药学上可接受的盐及其组合物。这些化合物包含如下结构所示的氨基酸侧链或其氨基酸衍生物和一氧化氮释放基团：其中R1是乙基或氨基酸侧链基团或其氨基酸衍生物，R2和是氨基酸侧链基团或其氨基酸衍生物，n为1〜10的整数。

6. 发明申请

US20070196496A1 Delivery systems for functional ingredients 审中-公开
标题翻译：功能成分的输送系统
公开(公告)号：US20070196496A1
公开(公告)日：2007-08-23
申请号：US11584748
申请日：2006-10-23
申请人： Michael Farber , Jonathan Farber
发明人： Michael Farber , Jonathan Farber
IPC分类号： A61K31/718 , A61K9/14
CPC分类号： A61K9/0056 , A61K31/718
摘要： Oral gel delivery systems are provided that comprise an ingestible matrix within which one or more functional ingredients are substantially uniformly and completely dispersed and in which degradation of the functional ingredient(s) is minimised or eliminated. The matrix of the delivery systems comprises a carbohydrate component that comprises one or more carbohydrates that exhibit good moisture binding and low gelatinisation temperature; a sugar component comprising one or more sugars, sugar syrups and/or sugar alcohols; a hydrocolloid component, and a solvent component comprising one or more polyhydric alcohols. The delivery systems can be formulated to comprise a range of functional ingredients including various drugs and nutritional supplements.
摘要翻译：提供口服凝胶递送系统，其包含可摄取的基质，其中一种或多种功能成分基本上均匀和完全分散，并且功能成分的降解被最小化或消除。递送系统的基质包括碳水化合物组分，其包含一种或多种表现出良好的水分结合和低糊化温度的碳水化合物; 糖组分，其包含一种或多种糖，糖浆和/或糖醇; 水胶体组分和包含一种或多种多元醇的溶剂组分。递送系统可以配制成包括一系列功能成分，包括各种药物和营养补充剂。

7. 发明授权

US07067150B2 Delivery systems for functional ingredients 失效
公开(公告)号：US07067150B2
公开(公告)日：2006-06-27
申请号：US10416547
申请日：2003-03-25
申请人： Michael Farber , Jonathan Farber
发明人： Michael Farber , Jonathan Farber
IPC分类号： A61K9/14
CPC分类号： A23G3/44 , A23G3/0021 , A23G3/0051 , A23G3/0068 , A23G3/366 , A23G3/368 , A23G3/40 , A23G3/42 , A23G3/48 , A23L33/175 , A23V2002/00 , A23V2250/5072 , A23V2250/5432 , A23V2250/1866 , A23V2250/5062 , A23V2250/2108 , A23V2250/264 , A23V2250/606 , A23V2250/306 , A23V2250/5118
摘要： The present invention provides oral delivery systems for functional ingredients, such as drugs, nutritional supplements, botanicals, and vitamins. The delivery systems comprise an ingestible matrix within which the functional ingredient(s) are substantially uniformly and completely dispersed and in which degradation of the functional ingredient(s) is minimised. The matrix comprises 1) one or more carbohydrate; 2) one or more sugar, sugar syrup and/or sugar alcohol; 3) one or more hydrocolloid; 4) one or more polyhydric alcohol; 5) one or more source of mono- or divalent cations, and 5) water. The combination of carbohydrate and hydrocolloid in the matrix ensures that the delivery system readily retains the solvent component and thereby prevents separation of the solvent from other components of the matrix. The invention also provides methods of preparing and using the delivery systems.

8. 发明授权

US06405020B1 Method and base station system for voice transmission via a radio interface in a digital radio communication system 有权
标题翻译：用于通过数字无线电通信系统中的无线电接口进行语音传输的方法和基站系统
公开(公告)号：US06405020B1
公开(公告)日：2002-06-11
申请号：US09535650
申请日：2000-03-24
申请人： Stefan Oestreich , Michael Farber , Meik Kottkamp
发明人： Stefan Oestreich , Michael Farber , Meik Kottkamp
IPC分类号： H04B1700
CPC分类号： H04L1/0014 , H04L1/0009 , H04L1/0016 , H04L1/0019 , H04L1/0026
摘要： A method for voice transmission via a radio interface in a digital radio communication system includes the step of transmitting at least one signal between a base station of a base station system and a radio station. At least one characteristic value relating to the transmission conditions of the radio interface is determined from this signal. The characteristic value is stored in at least one storage device and is taken into account at a later point in time in addition to currently determined characteristic values for a voice and channel coding on the transmitter side. A base station system for voice transmission via a radio interface in a digital radio communication system is also provided.
摘要翻译：一种通过数字无线电通信系统中的无线电接口进行语音传输的方法包括在基站系统的基站和无线电台之间发送至少一个信号的步骤。根据该信号确定与无线接口的发送条件有关的至少一个特征值。特征值存储在至少一个存储设备中，并且除了在发射机侧上的语音和信道编码的当前确定的特征值之外，还在稍后的时间点被考虑。还提供了一种用于通过数字无线电通信系统中的无线电接口进行语音传输的基站系统。

9. 发明申请

US20160361258A1 COMPOSITION FOR ENHANCING LIBIDO IN MAMMALS 审中-公开
标题翻译：用于增强羊肉中的LIBIDO的组合物
公开(公告)号：US20160361258A1
公开(公告)日：2016-12-15
申请号：US14735295
申请日：2015-06-10
申请人： Michael Farber
发明人： Michael Farber
IPC分类号： A61K9/127 , A61K31/341 , A61K9/00 , A61K31/352
CPC分类号： A61K9/127 , A61K9/006 , A61K9/14 , A61K9/2095 , A61K31/341 , A61K31/352 , A61K2300/00
摘要： The present invention features a compressible delivery formulation for buccal delivery, dosage forms and methods of using the same for increasing testosterone levels in a subject. The formulation, dosage forms and methods comprise effective amounts of 3,4-divanillyltetrahydrofuran, 7-methoxyflavone, 7,8-benzoflavone, and L-Dopa.
摘要翻译：本发明的特征在于用于口腔递送的可压缩递送制剂，剂型以及使用其可用于增加受试者中睾丸激素水平的方法。制剂，剂型和方法包括有效量的3,4-二苯乙烯基四氢呋喃，7-甲氧基黄酮，7,8-苯并异黄酮和L-多巴。

10. 发明申请

US20140148438A1 NITRIC OXIDE RELEASING AMINO ACID ESTER FOR TREATMENT OF PULMONARY HYPERTENSION AND OTHER RESPIRATORY CONDITIONS 有权
标题翻译：用于治疗肺动脉高压和其他呼吸道状况的硝酸氧化酶释放氨基酸
公开(公告)号：US20140148438A1
公开(公告)日：2014-05-29
申请号：US13825924
申请日：2011-09-22
申请人： Michael Farber
发明人： Michael Farber
IPC分类号： C07C203/04 , A61K45/06 , A61K31/22
CPC分类号： C07C203/04 , A61K9/0078 , A61K31/22 , A61K31/223 , A61K45/06 , A61K2300/00
摘要： There is provided compositions and methods for the treatment of respiratory conditions such as pulmonary hypertension and sickle-cell disease in a patient in need thereof. The composition and method are for treating a patient in need thereof by inhalation of a composition containing amino acid ester compounds comprising at least one nitric oxide releasing group and pharmaceutical salts thereof.
摘要翻译：提供了在有需要的患者中治疗呼吸道疾病如肺动脉高压和镰状细胞病的组合物和方法。组合物和方法用于通过吸入包含至少一种一氧化氮释放基团的氨基酸酯化合物及其药学盐的组合物来治疗有需要的患者。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式